Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

On June 24, 2026, Oxurion NV, based in Leuven, Belgium, announced it received a transparency notification from Atlas Special Opportunities II, LLC. The notification, dated June 23, 2026, revealed that Atlas held 5,442,909 shares of Oxurion as of June 22, 2026. This represented a stake that fell below the 5% threshold of the total 111,049,581 outstanding shares, due to the sale of voting securities.

This transaction follows Belgian transparency legislation which mandates disclosure when significant holdings change. Oxurion, traded on Euronext Brussels under the symbol OXUR, combines clinical research with technology to support pharmaceutical developments. The company emphasizes compliance with legislations and ensures stakeholders are informed of key changes.